financial guidance Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 The guidance for next year assumes, among other things, $6.0 billion in revenue from clinical research services provider PPD, which Thermo Fisher is set to acquire this year. LumiraDx, CA Healthcare Acquisition Revise Merger Terms to Lower Equity Value of Combined Company The firms said that lowering the pro forma enterprise value of post-merger LumiraDx is expected to make the new company more attractive to investors. SomaLogic Boosts Full-Year 2021 Revenue Guidance by 10 Percent The company said that it expects to exceed its previous full-year 2021 guidance of $66.7 million in revenues by 10 percent or more. Agilent Technologies Q3 Revenues Rise 26 Percent Revenues for Agilent's diagnostic and genomics group rose 44 percent to $346 million from $241 million in the year-ago quarter. 23andMe Q1 Revenues Rise 23 Percent The company said its revenue growth was primarily due to higher sales of its Personal Genome Service kit. Aug 9, 2021 Castle Biosciences Q2 Revenues Rise 79 Percent Aug 6, 2021 Twist Bioscience Fiscal Q3 Revenues Grow 65 Percent Aug 6, 2021 NeoGenomics Q2 Revenues Grow 40 Percent Aug 6, 2021 Meridian Bioscience Fiscal Q3 Revenues Drop 25 Percent Aug 5, 2021 Natera Q2 Revenues Grow 64 Percent Aug 5, 2021 Illumina Q2 Revenues Jump 78 Percent Aug 5, 2021 Bio-Techne Q4 Revenues Jump 47 Percent Aug 4, 2021 NanoString Technologies Q2 Revenues Increase 50 Percent Jul 30, 2021 DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand Jul 29, 2021 Qiagen Q2 Revenues Grow 28 Percent Jul 29, 2021 CareDx Q2 Revenues up 77 Percent Jul 28, 2021 Exact Sciences Q2 Revenues Rise 62 Percent Jul 28, 2021 Hologic Q3 Revenues Rise 42 Percent Despite Lower Demand for SARS-CoV-2 MDx Assays Jul 28, 2021 Thermo Fisher Scientific Q2 Revenues up 34 Percent Jul 26, 2021 PerkinElmer to Acquire BioLegend for $5.25B; Q2 Revenues Rise 51 Percent Jul 22, 2021 Roche Reports Diagnostics Revenue Up 51 Percent in H1 Jul 22, 2021 Danaher Q2 Revenues Rise 37 Percent, Driven by Life Sciences and Diagnostics Businesses Jul 22, 2021 Abbott Q2 Diagnostics Revenues Rise 63 Percent on COVID-19 Testing Demand Jul 12, 2021 Qiagen Reports Preliminary Q2 Revenues Above Guidance; Adjusts FY21 Expectations Downward Jun 1, 2021 Abbott Lowers FY21 Guidance as It Sees Sharp Decline in COVID-19 Test Revenue Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.